Any talk of TO is probably premature anyway. IMU will need a couple of really outstanding announcements before BP trigger any overt attempts to connect with IMU.
In any case, the way the SP has somewhat languished, any TO is not currently in the interest of shareholders. Lots of comments on HC about 30, 40 and 60 cent SP for a TO are somewhat insulting if IMU paves the way for a unique and effective cancer treatment.
I am always loathe to even give predictions on the SP - that crystal ball can be shattered by a single announcement. However, surely IMU (with the qualification that results need to be very positive) is worth much more than some posters have indicated - and maybe, IMU could even go it alone with the right partnerships/commercial deals.
I have very serious reservations that the IMU management would even be tempted by any offers and would consider them very low ball. Shareholders sentiment on HC would indicate the same feeling.
The IMU journey has really only started - and we have some way to go before the real value of IMU's research will show the true promise of what it can deliver. I believe we have 5 trials going on at the moment.
Having said that, I think the pointy end of research will make itself known by the end of 2024 - not really that far ahead.
So, 2024 is setting itself up as a very interesting year for IMU. Our conversations 112 months from now could be very different than they are now.
Happy new year for all IMU holders.
IMU Price at posting:
11.0¢ Sentiment: Buy Disclosure: Held
(20min delay)